Meidhof, S., Brabletz, S., Lehmann, W., Preca, B., Mock, K., Ruh, M., . . . Brabletz, T. (2015). ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol Med.
Stile di citazione ChicagoMeidhof, Simone, et al. "ZEB1-associated Drug Resistance in Cancer Cells Is Reversed By the Class I HDAC Inhibitor Mocetinostat." EMBO Mol Med 2015.
Citazione MLAMeidhof, Simone, et al. "ZEB1-associated Drug Resistance in Cancer Cells Is Reversed By the Class I HDAC Inhibitor Mocetinostat." EMBO Mol Med 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.